Expressive

rs112558930 (ZNF619P1/HMGN1P19): Biomarker GWAS Locus

Key takeaways

  • This variant near ZNF619P1 and HMGN1P19 pseudogenes was identified in a major UK Biobank genome-wide study of blood and urine lab results.
  • The source study included 363,228 participants and identified 1,857 genetic loci across 35 biomarker traits.
  • Specific trait associations and effect sizes for this variant are not detailed in the available study text.
  • Findings were cross-validated in an independent FinnGen cohort of 135,500 individuals.
  • This is population-level research with no established clinical application for individuals.

Key takeaways

  • This genetic variant falls near two pseudogenes (gene-like sequences that do not produce functional proteins): ZNF619P1 and HMGN1P19.
  • It was identified in a large genome-wide study of 35 blood and urine biomarkers in 363,228 UK Biobank participants.
  • The study identified 1,857 genetic loci across all 35 biomarker traits, with this locus among them.
  • Specific trait associations and effect sizes for this variant are not detailed in the available study text.
  • This is large-scale population research; no individual clinical conclusions should be drawn.

What the research says

A genome-wide association study (GWAS - a method that scans millions of genetic positions to find variants statistically linked to traits) of 35 blood and urine clinical laboratory measurements was conducted in 363,228 UK Biobank participants, with meta-analysis across White British (n=318,953), non-British White (n=23,582), African (n=6,019), and South Asian (n=7,338) ancestry groups, identifying 1,857 loci containing 3,374 fine-mapped (statistically narrowed to the most likely causal position) associations. Polygenic risk scores (tools that combine many small genetic effects into a single predictive score) built from this data were validated in an independent FinnGen cohort (n=135,500), where they improved genetic risk stratification for chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis relative to single-disease prediction models.

Reported associations

  • Blood and urine biomarkers: This variant was detected within a GWAS of 35 clinical laboratory measurements in 363,228 UK Biobank individuals; the specific biomarker(s) it is associated with and the direction and magnitude of effect are not specified in the available text from this study.

Evidence quality

The source study is one of the largest GWAS analyses of clinical biomarkers conducted to date, with a discovery cohort of 363,228 participants and validation in an independent FinnGen cohort of 135,500 individuals. Association results were benchmarked against 42 previously published cohorts across 25 biomarkers, showing high overall agreement. Fine-mapping was applied to narrow broad association signals to the most likely causal variants, and linkage disequilibrium score intercepts were consistent with well-controlled population structure. However, the specific association data for rs112558930, including which biomarker(s) it is linked to, the direction of effect, and any effect size measures, are not available in the provided text excerpts. The evidence quality for this specific variant therefore cannot be fully characterised from the available source material, and the association should be considered preliminary until fully documented data are reviewed.

Lifestyle considerations

No lifestyle considerations on file for this variant.

Frequently asked questions

What genes are near rs112558930?

rs112558930 is located near ZNF619P1 and HMGN1P19, both of which are pseudogenes - gene-like sequences in the genome that do not produce functional proteins.

What trait is rs112558930 associated with?

This variant was identified in a large genome-wide study of 35 blood and urine biomarkers in the UK Biobank. The specific biomarker it is most strongly linked to is not detailed in the available study text.

How large was the study that found rs112558930?

The discovery study included 363,228 unrelated UK Biobank participants across multiple ancestry groups, with findings validated in an independent FinnGen cohort of 135,500 individuals.

Is rs112558930 clinically significant?

The available evidence comes from population-level genetic research. No clinical significance has been established for this variant based on the current study data.

What is a pseudogene and why does it matter for rs112558930?

A pseudogene is a DNA sequence that resembles a gene but does not produce a functional protein. rs112558930 sits near two pseudogenes, ZNF619P1 and HMGN1P19, meaning the biological mechanism linking this variant to any trait remains unclear from current data.